Euroopa Liit - eesti - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - rinnanäärmed - antineoplastilised ained - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Eesti - eesti - Ravimiamet

cheplapharm arzneimittel gmbh - kandesartaan - tablett - 16mg 100tk; 16mg 15tk; 16mg 90tk; 16mg 14tk; 16mg 300tk; 16mg 30tk; 16mg 28tk; 16mg 56tk; 16mg 250tk

Eesti - eesti - Ravimiamet

recordati ireland limited - metoprolool - toimeainet prolongeeritult vabastav tablett - 50mg 100tk; 50mg 30tk; 50mg 28tk; 50mg 98tk

Eesti - eesti - Ravimiamet

gruenenthal gmbh - rosuvastatiin - õhukese polümeerikattega tablett - 5mg 7tk; 5mg 30tk; 5mg 90tk; 5mg 14tk; 5mg 15tk; 5mg 98tk; 5mg 28tk; 5mg 100tk; 5mg 42tk

Eesti - eesti - Ravimiamet

cheplapharm arzneimittel gmbh - kandesartaan+hüdroklorotiasiid - tablett - 32mg+12,5mg 300tk; 32mg+12,5mg 7tk

Eesti - eesti - Ravimiamet

cheplapharm arzneimittel gmbh - kandesartaan - tablett - 32mg 250tk; 32mg 7tk; 32mg 28tk; 32mg 98tk; 32mg 30tk; 32mg 100tk

Eesti - eesti - Ravimiamet

cheplapharm arzneimittel gmbh - kandesartaan+hüdroklorotiasiid - tablett - 16mg+12,5mg 30tk; 16mg+12,5mg 90tk; 16mg+12,5mg 300tk; 16mg+12,5mg 14tk; 16mg+12,5mg 98tk

Eesti - eesti - Ravimiamet

laboratoires juvise pharmaceuticals - anastrosool - õhukese polümeerikattega tablett - 1mg 84tk; 1mg 28tk; 1mg 98tk; 1mg 300tk; 1mg 20tk; 1mg 30tk; 1mg 100tk

Eesti - eesti - Ravimiamet

gruenenthal gmbh - rosuvastatiin - õhukese polümeerikattega tablett - 10mg 90tk; 10mg 42tk; 10mg 7tk; 10mg 28tk; 10mg 14tk; 10mg 100tk; 10mg 15tk; 10mg 30tk

Eesti - eesti - Ravimiamet

gruenenthal gmbh - rosuvastatiin - õhukese polümeerikattega tablett - 20mg 7tk; 20mg 90tk; 20mg 14tk; 20mg 98tk; 20mg 42tk; 20mg 100tk; 20mg 15tk